靶向 PD-L1 的纳米囊泡免疫疗法治疗胆管癌
Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.
肿瘤细胞治疗研究
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov、CDE 与 ChiCTR 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。